Business
CareDx The Transplant Company Releases Inaugural Environmental, Social and Governance Report
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and
About this update from Caredx, Inc.
[{"type":"text","content":" SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--\nCareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the release of its first environmental, social and governance (ESG) report.\n\n“At CareDx, our mission and 100% dedication to improving the transplant ecosystem with innovative and intelligent solutions to improve patient outcomes shapes every aspect of our business and seamlessly integrates with an ESG framework,” said Reg Seeto, CareDx CEO and President. “As a leader in transplantation, we have a great responsibility to the transplant community, and using this framework is a natural step in our company’s evolution as we search for ways to continue to exemplify our values through actions which have a meaningful impact on our community, patients, and other stakeholder groups.”\n\nKey Accomplishments:\n\n\nStrong investment in transplant research innovation\n\n\nInvestment in digital health solutions to help improve patient’s pre- and post-transplant journey\n\n\nIntroduction of company values which drive innovation, patient centricity, accountability, continuous improvement, collaboration, and can-do attitude\n\n\nProvided vital patient education to help transplant recipients navigate their exposure to COVID while continuing to offer RemoTraC™, an at-home phlebotomy testing service, to ensure continuity of care for immune-compromised patients\n\n\nHannah Valantine and Art Torres, recognized health equity experts, joined the CareDx Board of Directors to help address systemic healthcare disparities\n\n\nSupported MOTTEP’s (Minority Organ Tissue Transplant and Education Program) efforts to increase organ donations and community-based disease prevention education in underserved communities\n\n\n“CareDx has been a strong supporter of our work at MOTTEP, which is aimed at increasing minority organ donations and addressing health inequities which disproportionately result in a greater incidence of heart and kidney transplant failure in underserved minority communities,” said MOTTEP founder Dr. Clive Callender.\n\nTo view the report, follow this link.\n\nAbout CareDx – The Transplant Company\n\nCareDx, Inc., headquartered in South San Francisco, California, i...